LifePoint logo

LifePoint(OTC) LFPI

Market Cap$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1993)-100%
5 Year-99%
1 Year+0%
1 Month-100%
$0.00
+0.00%
+0.00Today
LifePoint last closing stock price
MetricPriceDate
Last closeUSD 0.002026-10-13
LifePoint stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-99.67%USD 0.002026-06-11
1 month-99.67%USD 0.002026-06-11
3 month-99.67%USD 0.002026-06-11
Year to date+0%USD 0.002025-12-22
1 year+0%USD 0.002025-08-15
3 year+0%USD 0.002023-09-27
5 year-99%USD 0.002021-09-24
Since inception-100%USD 5.131993-10-26

LifePoint Financials at a Glance

Market Cap

$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$81.90K

Net Income (TTM)

-$18.15M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-10.07 (Low)

Price

$0.00

Volume

74,982

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 20, 2002

LFPI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About LifePoint

LifePoint, Inc. is a healthcare company specializing in the development, production, and sale of the IMPACT Test System, a diagnostic testing device. Established in 1992, the company serves various markets, including emergency medical services, retail pharmacies, and home healthcare.

Products and Services
  • IMPACT Test System for diagnostic testing
  • Services for emergency medical services and public safety organizations
  • Home healthcare solutions for patient monitoring
Growth Outlook
  • Expansion into new markets is anticipated to drive revenue growth
  • Increased demand for diagnostic testing solutions post-pandemic
  • Strategic partnerships may enhance product distribution and visibility
Financial Highlights
  • Recent quarterly revenue of $5,836 indicates potential for recovery
  • Trailing twelve months (TTM) gross profit margin stands at 3.86%
  • Current ratio of 2.75 suggests strong short-term financial health
LifePoint, Inc. operates in the medical instruments and supplies sector, focusing on innovative diagnostic solutions. The company's flagship product, the IMPACT Test System, is designed to meet the growing needs of various healthcare markets. With a solid foundation and a commitment to expanding its reach, LifePoint is positioned to capitalize on the increasing demand for effective diagnostic tools. Recent financial data shows a revenue of $5,836 for the latest quarter, reflecting a potential turnaround. The TTM gross profit margin of 3.86% indicates operational efficiency, while a current ratio of 2.75 highlights the company's ability to meet short-term obligations. As the healthcare landscape evolves, LifePoint, Inc. is poised for growth through strategic initiatives and market expansion.
AI Generated • Sep 29, 2026

Industry

Healthcare Providers and Services

Headquarters

Ontario, CA 91761, US

LFPI Financials

Key Financial Metrics (TTM)

Gross Margin

385.72%

Operating Margin

40514.75%

Net Income Margin

82332.96%

Return on Equity

-484.61%

Return on Capital

-110.20%

Return on Assets

-172.91%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

102.09M

Volume

74.98K

Avg. Volume

1.15K

Financials (TTM)

Gross Profit

-$2.48M

Operating Income

-$9.63M

EBITDA

-$16.71M

Operating Cash Flow

-$9.52M

Capital Expenditure

-$150.30K

Free Cash Flow

-$9.67M

Cash & ST Invst.

$2.19M

Total Debt

$186.61K

LifePoint Performance Analysis

LifePoint sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42004-03-31N/A
Q12004-06-30N/A
Q22004-09-30N/A
Q32004-12-31-92.3%
LifePoint sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42004-03-31-394.1%
Q12004-06-3082.9%
Q22004-09-3045.0%
Q32004-12-31-59.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2004YOY CHG

Revenue

$5.84K

N/A

Gross Profit

-$960.63K

N/A

Gross Margin

-164.60%

N/A

Market Cap

$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.92

N/A

Employees

52

N/A

Net Income

-$3.04M

-70.1%

EBITDA

-$2.28M

-88.6%

Quarterly Fundamentals

Name
Q3 2004YOY CHG

Total Cash

$2.19M

-43.4%

Total Debt

$186.61K

-51.7%

Accounts Receivable

$52.36K

N/A

Inventory

$2.44M

+0.9%

Long Term Debt

$59.50K

-49.1%

Short Term Debt

$127.11K

-52.8%

Return on Assets

-1.73%

N/A

Return on Invested Capital

-1.15%

N/A

Free Cash Flow

-$2.05M

-46.9%

Operating Cash Flow

-$2.05M

-46.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SECISector 10, Inc.
$0.00+0.00%
TRVNTrevena, Inc.
$0.00+0.00%
SDCCQSmileDirectClub Inc Class A
$0.00+0.00%
EVLOEvelo Biosciences, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$12.00-20.88%
EWZiShares - iShares Msci Brazil ETF
$32.57-23.54%
ITUBItaú Unibanco
$7.29-24.66%
XPXP
$14.75-51.50%

Questions About LFPI

What is the current price of LifePoint?

LifePoint is trading at $0.00 per share.

What is the 52-week range for LifePoint?

Over the past 52 weeks, LifePoint has traded between $0.00 and $0.00.

How much debt does LifePoint have?

LifePoint total debt is unavailable.

How much cash does LifePoint have on hand?

LifePoint does not have cash on hand data available.

What is LifePoint’s dividend yield?

LifePoint does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.